Pharmaceutical

MOMA Therapeutics and Roche sign cancer drug discovery deal

MOMA Therapeutics and Roche have signed a strategic partnership and licensing agreement for discovering drug targets for cancer.

Jan 5, 2024 - 18:00
MOMA Therapeutics and Roche sign cancer drug discovery deal
MOMA Therapeutics and Roche have signed a strategic partnership and licensing agreement for discovering drug targets for cancer.
Read the original article

Tags:

Previous Article

Insilico teams up with Menarini for breast cancer KAT6 inhibitor

Next Article

AbbVie and Umoja to develop new CAR-T therapies for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Why brain decoding is not mind reading — and why that matters

Opinion: Why brain decoding is not mind reading — and w...

Jun 8, 2023

Listen: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers

Listen: Illumina’s boardroom intrigue, the next big Alz...

Apr 7, 2023

Formation Bio secures $372m funds for AI-driven drug platform

Formation Bio secures $372m funds for AI-driven drug pl...

Jun 28, 2024